ABEO

ABEO EBITDA Growth

-189.16%TTM

Period ending:

ABEO TTM EBITDA YoY %%
ABEO TTM EBITDA YoY %1231.06%-8402.23%
1997-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

ABEO ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 116 observations from Sep 30, 1997 to Jun 30, 2026.

Abeona Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-189.1612%
298.8033%
238.793%
238.3448%
268.433%
48.9538%
-11.9612%
-41.8385%
-10.2904%
-104.1936%
-24.4788%
-7.3827%
-8.5066%
19.8031%
8.44%
5.2065%
10.8667%
-2.6866%
-4.363%
-6.0946%
15.9056%
32.4219%
37.0911%
41.761%
27.8584%
-0.3451%
-18.7577%
-56.5019%
-104.8954%
-98.7409%
-114.1889%
-85.9267%
-61.1784%
-54.4729%
-26.2713%
-51.8327%
-11.0961%
-18.4063%
-50.6335%
-34.6352%
-161.7882%
-8.9026%
6.1491%
20.5427%
45.9845%
-1,942.9434%
-359.7147%
-7,469.9761%
1.749%
103.1686%
115.8127%
100.8342%
-18.782%
-603.8205%
-2,647.7635%
-220.0026%
-45.3346%
51.4019%
82.4578%
-6.9097%
6.9523%
11.8713%
20.155%
18.7687%
-0.7193%
-1.6181%
46.3847%
50.4289%
44.4597%
42.0525%
-307.9907%
-1,985.5505%
-1,502.7145%
-618.5781%
-328.6245%
45.1572%
139.8882%
155.6551%
131.42%
75.0079%
61.8063%
26.0455%
25.1156%
19.3663%
1.666%
-1.173%
-9.4053%
-10.9861%
3.1508%
14.1984%
8.7222%
4.5131%
-18.1477%
-35.7294%
-41.0667%
-24.686%
-17.724%
-6.4762%
-1.7918%
-25.8642%

Compare ebitda growth

All ABEO financial metrics · ABEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.